Key result
Premature acute coronary syndrome was associated with a lower risk of in-hospital mortality, stroke, and myocardial reinfarction compared to nonpremature ACS (P<0.001).
Why the study?
ACS is less frequent in young adults but has become a significant health problem linked to increasing modifiable risk factors, warranting characterization of premature vs nonpremature ACS.
Does premature ACS compared to nonpremature ACS have different clinical outcomes in patients admitted with ACS?
Cohort (n=29,870)
Yes
Does premature ACS compared to nonpremature ACS have different clinical outcomes in patients admitted with ACS?
p-value: p=<0.001
Premature ACS accounts for 25% of ACS admissions and is associated with a better clinical prognosis compared to nonpremature ACS, despite a higher prevalence of modifiable risk factors.
Premature ACS tied to modifiable risks yet lower in-hospital events; leaves open optimal long-term secondary prevention strategies in this subgroup.
INTRODUCTION: Acute coronary syndrome (ACS) is less frequent in young adults, but it has become a significant health problem, associated with the increasing prevalence of modifiable risk factors. OBJECTIVES: To characterize patients admitted with premature ACS, comparing with those with nonpremature ACS. METHODS: We performed a retrospective study encompassing patients of the Portuguese Registry (ProACS), comparing two groups: one composed of men less than 55 and women less than 65 years old; and other with men ≥55 and women ≥65 years old at the ACS admission. The primary endpoint was the composite of in-hospital mortality, stroke and myocardial reinfarction (re-MI). RESULTS: A total of 29 870 patients were enrolled and 25% had premature ACS, with a mean age of 50 ± 7 years old. They had a larger prevalence of smoking habits, obesity and dyslipidemia. ST-segment elevation MI (STEMI) was the main admission diagnosis in young patients and coronary angiogram mainly revealed one vessel disease in this subgroup. They had a lower Killip-Kimball (KK) class and mostly preserved left ventricular ejection fraction (LVEF). Composite endpoint was more frequent in nonpremature ACS patients. Nonpremature age, presentation with syncope or cardiac arrest, KK class >1, multivessel disease and LVEF <40% were independent predictors of the primary endpoint ( P < 0.001). Younger patients had lower rates of in-hospital all-cause mortality, re-MI and stroke. One-year all-cause mortality and 1-year cardiovascular and non-cardiovascular readmissions were also lower. CONCLUSIONS: Premature ACS affects 25% of the ACS population, mostly presenting with STEMI, but generally associated with better clinical evolution. Nevertheless, prevention measures are essential to correct modifiable cardiovascular risk factors and reduce coronary events.
No takes yet. Share an insight, caveat, or question.
A 2022 study conducted a cohort in Acute coronary syndrome (n=29,870). Premature acute coronary syndrome vs. Nonpremature acute coronary syndrome was evaluated on composite of in-hospital mortality, stroke and myocardial reinfarction (re-MI) (p=<0.001). Premature acute coronary syndrome was associated with a lower risk of in-hospital mortality, stroke, and myocardial reinfarction compared to nonpremature ACS (P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: